Remedy Meds Review: $299 Semaglutide, Billed 13 Times a Year

Compounded semaglutide is $299 and compounded tirzepatide is $399, each buying one 28-day supply, with no second fee on top — that part Remedy gets right. The lower numbers are prepaid terms: semaglutide is $747 for three months ($249 a month), $1,194 for six ($199), or $2,148 for twelve ($179); tirzepatide is $1,047, $1,794 and $3,588. Every one of those is charged in a single payment at the start of the term. None of these figures is published on the site — they were read on August 9, 2026 off the product catalog inside the intake app's own client bundle, which lists each item price verbatim.

Because Remedy says so. Its Weight Loss Warranty conditions require that you "filled out the refill form and received a shipment of your prescribed compounded medication every twenty-eight (28) days throughout the twelve (12) month period, for a total of thirteen (13) shipments." The SKU ids agree — the base tier is `semaglutide-USD-every-28-days` while the bundles are `-every-3-months` — even though the plan card labels the 28-day tier "monthly". Thirteen 28-day cycles is 364 days. So $299 a month is $3,887 a year and $399 is $5,187, and any comparison you make against a genuinely monthly seller at the same sticker price is understating Remedy by one full payment.

No, and this is worth stating plainly because the funnel shows something that looks like one. A "Remedy Membership Plan" tile appears with $99 beside it. It is never billed: in the catalog that object is `type: "mock_plan"` with `price: 0` and a `visual_price` of 99, and the function that assembles what checkout actually charges skips every mock plan. The Terms match — the fee "is inclusive of both medication shipments and ongoing access to licensed clinicians and the Remedy Meds platform". So the medication price is the entire recurring bill, which is why the walk-away column here equals the sticker rather than doubling it.

Assume not. Remedy bills you when you finish the intake form, before the clinical review, and its Terms say that "in the event medication is not prescribed after your initial consultation, once paid, your Program Membership Fee is non-refundable" — qualified only by whatever checkout states about that first payment, which is the one screen you should read slowly. If you took a bundle, the exposure is the whole term: cancelling stops the next renewal but recovers nothing from the current one, and Remedy requires 48 hours' notice before the renewal date. There is also no partial credit for cycles you skip — charges continue "even if you do not complete the refill form and do not receive a medication shipment".

A full refund of twelve months of fees if you do not reach the goal weight you entered at enrollment — hedged by conditions most people will trip. You must stay continuously enrolled for twelve months and take all thirteen shipments, with any lapse, cancellation or pause voiding it. It is void if you microdose at any point, void if you are switched to a branded GLP-1, and void if your BMI drops below 18.5. Your goal weight cannot have been more than 20% below your starting weight. It is not prorated, so eleven months earns nothing. And you must email a claim within 35 days of the thirteenth shipment, then either get a licensed provider to attest your weight in writing within fourteen days or record a video of yourself stepping onto a calibrated scale holding a code Remedy gives you. It is a real promise; it is not "if it doesn't work, you don't pay".

It is half the standard dose split across two injections a week rather than one, priced at $189 per 28-day cycle for either semaglutide or tirzepatide — $2,457 across a thirteen-charge year. It is the cheapest way into this provider by a wide margin, especially for tirzepatide, where the standard dose costs $399 against the same $189. Two trade-offs are disclosed: microdosing voids the Weight Loss Warranty outright, and its refill form runs every three months instead of every cycle. There is no prepay bundle for it, which means the advertised price and the real price are the same number — the only row on this review where that is true.

Almost certainly. The state selector inside Remedy's own intake offers 51 options — all fifty states plus the District of Columbia — with no restricted or limited tier of the sort other telehealth funnels carry, and the quiz shows a "We deliver to [your state]" confirmation before it continues. One thing to ignore if you go looking: the client bundle contains a fourteen-state array that looks like an exclusion list. It is not. The function reading it routes to an enclomiphene intake and only runs for the Keeps brand, which shares this platform with Remedy Meds, Prime Health, Nurx and Blue Haven RX.

One thing, narrowly. On September 9, 2025 FDA wrote to Remedy Meds about remedymeds.com, which it had reviewed that August. The cited claims were "Same active ingredient as Ozempic and Wegovy" and "Same active ingredient as Mounjaro and Zepbound", and FDA's objection was that "Compounded drug products are not FDA-approved. Your claims imply that your products are the same as an FDA-approved product when they are not." That is a misbranding finding under FDCA 502(a) and 502(bb) — a labelling problem, not a safety one. Nothing in the letter concerns sterility, potency, contamination, or the compounding pharmacies. FDA's index shows no close-out letter. Worth knowing: those two sentences were still being served by Remedy's intake bundle, word for word, when this review was checked on August 9, 2026.

Badly. Remedy lists Ozempic at $1,299 and Zepbound at $1,399 per 28-day cycle, which on its thirteen-cycle year is $16,887 and $18,187. Novo Nordisk and Eli Lilly both sell those products direct to self-pay patients for a fraction of that, and going through a telehealth intermediary to buy a branded drug at four figures a month adds cost without adding anything. Remedy is a compounded-medication business; the branded listings are there for completeness, and the Weight Loss Warranty explicitly does not apply to them.